Global high throughput screening market is anticipated to exhibit lucrative growth through to 2022 owing to its associated advantages such as high speed, high sensitivity, and ease of support which increases its adoption in research and drug discovery. Applications of this market’s segments for identification of enzymes, ligands, ion-channels, and pharmacological targets drive the market growth. Moreover, rise in number of advantages of these techniques such as rapid identification of antibodies and active compounds which alter the metabolic pathways and there response also impacts the market growth positively. Assay development and primary screening techniques for analysis of different pharmaceutical and biomolecular compounds have created significant potential for the growth of this market. Furthermore, the expected patent expiration of important biologics, up gradation in hardware and software technologies used in high content screening techniques are also expected to promote the market growth during the forecast period.
To request a sample copy or view summary of this report, click the link below:
Rising technological advancements in these techniques, increasing investment by drug discovery organizations, incorporation of nuclear magnetic resonance technology & mass spectrometry for elemental analysis in compounds, and development of assays that use affinity chromatography for identification of complex biomolecules are high impact rendering drivers for market growth. Furthermore, increased applications of screening techniques in stem cell research, molecular biology and toxicology, are anticipated to fuel the market growth in the coming years. Technological advancements such as automation in HTS software, robotic arms, database system, and robotic workstations that are implemented by biopharmaceutical R&D companies and analytical laboratories drives the growth of the market significantly during the next seven years.
Geographical analysis of the market divides it into Europe, North America, Latin America Asia Pacific, and MEA. North America held the largest share of market revenue in 2014. The factors attributing towards high share of the market include enhancement in infrastructure quality of clinical and laboratory research firms, and rising application of cell culture and cell line techniques in cancer research. Emerging economies such as China and India in the Asia Pacific region are anticipated to exhibit significant growth rate throughout the forecast period due to the presence of a large population base, and increasing corporate and government investment in the biotechnology and biopharmaceutical industry. Furthermore, improvements in healthcare infrastructure for diagnosis and prognosis of high risk and chronic infectious diseases are also expected to induce growth in this market. The key players of this market include Sigma-Aldrich Corporation, Roche Applied Sciences, Beckman Coulter Inc., Luminex Corporation, Life Technologies Corporation, Agilent Technologies Inc., and Aurora Biomed Inc. The companies are involved in competitive strategies in order to maintain the market position such as collaborations with genomics research institutes and laboratories.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.